Its downregulation in MS contributes both to the regulation of Th1 cells, which are implicated in MS immune control since they secrete gamma interferon, which, in turn, exacerbates inflammatory symptoms of the pathology, and to the differentiation of Th17 cells [108]. The gene discussed is IFNG; the disease is myeloid sarcoma.